RECCHIA, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.280
EU - Europa 4.496
AS - Asia 4.376
SA - Sud America 672
AF - Africa 106
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.991
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.089
SG - Singapore 1.411
IT - Italia 1.289
GB - Regno Unito 1.165
CN - Cina 1.145
VN - Vietnam 519
HK - Hong Kong 505
BR - Brasile 504
SE - Svezia 501
DE - Germania 356
FR - Francia 216
RU - Federazione Russa 203
FI - Finlandia 170
UA - Ucraina 166
TR - Turchia 113
KR - Corea 104
IN - India 97
CA - Canada 82
ID - Indonesia 81
NL - Olanda 80
JP - Giappone 64
BG - Bulgaria 60
BD - Bangladesh 59
MX - Messico 58
AR - Argentina 56
BE - Belgio 51
IQ - Iraq 48
AU - Australia 47
ZA - Sudafrica 44
AE - Emirati Arabi Uniti 34
IE - Irlanda 32
LT - Lituania 31
BZ - Belize 28
ES - Italia 26
PK - Pakistan 26
CO - Colombia 24
EC - Ecuador 22
VE - Venezuela 21
MY - Malesia 20
PL - Polonia 20
AT - Austria 19
IR - Iran 19
CH - Svizzera 16
CL - Cile 16
CZ - Repubblica Ceca 16
JO - Giordania 16
PH - Filippine 16
SA - Arabia Saudita 16
MA - Marocco 15
UZ - Uzbekistan 12
NP - Nepal 11
AL - Albania 10
NZ - Nuova Zelanda 10
TN - Tunisia 10
PT - Portogallo 9
SI - Slovenia 9
LU - Lussemburgo 8
PE - Perù 8
RO - Romania 8
TH - Thailandia 8
BO - Bolivia 7
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
PY - Paraguay 7
RS - Serbia 7
GR - Grecia 6
TW - Taiwan 6
UY - Uruguay 6
AZ - Azerbaigian 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
IL - Israele 5
PS - Palestinian Territory 5
ET - Etiopia 4
KZ - Kazakistan 4
NG - Nigeria 4
OM - Oman 4
PA - Panama 4
QA - Qatar 4
CR - Costa Rica 3
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
NO - Norvegia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CY - Cipro 2
HN - Honduras 2
HR - Croazia 2
LV - Lettonia 2
MD - Moldavia 2
PR - Porto Rico 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AW - Aruba 1
Totale 19.975
Salva come PNG Salva come JPEG
Città #
Fairfield 1.041
Singapore 970
Ashburn 941
Santa Clara 900
Southend 746
Chandler 598
Woodbridge 586
Houston 497
Hong Kong 483
Seattle 382
San Jose 366
Cambridge 360
Ann Arbor 336
Wilmington 317
Jacksonville 301
Dearborn 279
Nyköping 274
Hefei 261
Beijing 241
Modena 209
Los Angeles 189
London 186
Chicago 181
Ho Chi Minh City 141
Council Bluffs 127
Helsinki 125
Bologna 120
Hanoi 120
New York 117
The Dalles 104
San Diego 100
Seoul 89
Princeton 73
Buffalo 68
Moscow 64
Jakarta 63
Salt Lake City 63
Lauterbourg 59
Sofia 59
Bremen 55
Eugene 52
Brussels 49
Izmir 48
Shanghai 48
Milan 43
Elk Grove Village 40
Munich 39
Orem 39
São Paulo 39
Frankfurt am Main 36
Dallas 35
Columbus 32
Da Nang 32
Redwood City 32
Rome 32
Tampa 32
Des Moines 30
Falls Church 30
Belize City 28
San Francisco 27
Parma 26
Tokyo 26
Toronto 26
Dong Ket 25
Dublin 25
Haiphong 25
Paris 24
Phoenix 24
Brooklyn 21
Mexico City 21
Bari 20
Boardman 20
Rio de Janeiro 20
Montreal 19
Baghdad 18
Boston 18
Las Vegas 18
Amsterdam 17
Atlanta 17
Chennai 17
Johannesburg 17
Lancaster 17
Mumbai 17
Warsaw 16
Denver 15
Guangzhou 15
Nuremberg 15
Sterling 15
Stockholm 15
Trieste 15
Biên Hòa 14
Poplar 14
Turin 14
Wuhan 14
Albuquerque 13
Fremont 13
Nanjing 13
Portsmouth 13
Reggio Emilia 13
Amman 12
Totale 13.651
Salva come PNG Salva come JPEG
Nome #
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 564
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 422
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 413
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 404
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 402
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 399
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 393
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 387
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 387
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 387
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 371
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 362
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 360
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 358
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression 355
Comprehensive genomic access to vector integration in clinical gene therapy 355
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 354
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 350
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 350
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 330
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 329
Site-specific integration by the adeno-associated virus rep protein 321
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 313
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 311
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 309
A single epidermal stem cell strategy for safe ex vivo gene therapy 308
Long-Term Skin Regeneration From a Gene-Targeted Human Epidermal Stem Cell Clone 300
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy 300
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 299
Nuclear architecture dictates HIV-1 integration site selection 296
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 286
Tracking gene-modified T cells in vivo. 285
Site-specific integration into the human genome: Ready for clinical application? 284
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 283
AAV-CRISPR Persistence in the Eye of the Beholder 283
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 277
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 269
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 269
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 265
Defining the lentiviral integrome in human hematopoietic cells 257
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 251
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 246
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 244
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 243
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 240
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 236
Immunotherapy: ANTI-GD2 CAR T CELLS AGAINST SMALL CELL LUNG CANCER 235
Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector 232
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 228
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector 227
Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration 224
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells 224
Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination 220
Targeted integration of a large transgene cassette by TALEN and ZFN-mediated homologous recombination. 216
Gene editing prospects for treating inherited retinal diseases 216
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 214
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 205
Transcriptional and epigenetic analyses of the DMD locus reveal novel cisâ acting DNA elements that govern muscle dystrophin expression 198
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 196
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 175
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 174
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 168
Corrigendum to: “Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression”. [Biochim. Biophys. Acta Gene Regul. Mech. 2017 Nov;1860(11):1138–1147.] (Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2017) 1860(11) (1138–1147), (S1874939917301359), (10.1016/j.bbagrm.2017.08.010)) 157
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 157
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 157
Collagen VII gene delivery via an Adeno-Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 154
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 153
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 150
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 148
The Journal of Gene Medicine European Society of Gene Therapy Young Investigator Award 2004 143
TALEN-mediated in situ correction of a genetic defect by homologous recombination into the native locus 136
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 133
Engineered nucleases-mediated in situ correction of a genetic defect by homologous recombination into the native locus 131
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 123
Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts 122
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 39
Totale 20.262
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021619 0 0 0 0 0 0 0 0 0 288 217 114
2021/20221.756 77 173 208 102 113 101 132 123 145 112 279 191
2022/20231.921 211 207 165 218 243 257 50 160 207 25 96 82
2023/20241.186 53 72 93 99 217 70 113 147 28 84 83 127
2024/20253.502 105 46 131 229 664 517 274 251 355 184 341 405
2025/20265.685 419 221 428 737 1.242 425 755 258 674 526 0 0
Totale 20.262